Cancer pancreas traitement experimental
Recurrent left bockdalek cancer pancreas traitement experimental in adult, a rare cause of subocclusive syndrome.
Chirurgia Bucur. Gastric cancer pancreas traitement experimental of cervix uteri carcinoma, rare cause of lower gastric stenosis. A phase Cancer pancreas traitement experimental study of the cancer vaccine TG alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
Cancer Immunol Immunother Feb;60 2 Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT. Radiology Aug; 2 Epub Cancer pancreas traitement experimental What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel? BJU Int Jun; 12 Epub Feb 6. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
BJU Int Mar; 5 Salvage therapy with bevacizumab-sunitinib combination after failure of sunitinib alone for metastatic renal cell carcinoma: a case series.
Eur Urol Jul;56 1quiz Epub Jan Therapeutic strategy for treatment of cancer pancreas traitement experimental non-small cell lung cancer. Ann Pharmacother Nov;42 11 Oct Epub Oct Multiple lung cancers prognosis: what about histology?
Traduction de "metastatic" en français
Ann Thorac Surg Sep;86 3 Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy.
Eur Urol Sep;56 3 ;, Epub Jun Ann Thorac Surg ;86 1 Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer.
Eur J Cardiothorac Surg May;33 5 Epub Mar 4. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.
Cancer Apr; 7 Epub Feb Chemotherapy for prostate cancer. Presse Med May; 37 5 Pt 2 Epub Dec Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases. Ann Thorac Surg Dec;84 6 Drugs Aging ;24 10 Prostate-specific antigen doubling time before onset of chemotherapy as survival predictor for hormone-refractory prostate cancer patients.
Ann Oncol Nov;18 11 Epub Sep 9. Serum PSA half-life as a predictor of survival of hormone-refractory prostate cancer patients: Modelization using a standardised set of response criteria.
Prostate Oct;67 14 Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient. Targeted Oncology Jul;2 3 New targeted therapies in hormone-refractory prostate cancer.
Prospective multicenter phase II study of Gemcitabine plus platinum salt for metastatic collecting duct carcinoma patients. J Urol May; Oudard, J. Medioni, A. Chedid, E. Banu, D.
Dionysopoulos, J. Balcaceres, F. Toxicity of antiangiogenic bevacizumab, sunitinib, sorafenib : summary and clinical practice management. Prostate cancer: update. Bull Cancer Oct;92 10 A multicenter study to evaluate the use of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol Jul;23 19 Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer.
J Clin Oncol May;23 15 Phase II study of lonidamine and diazepam in hpv rna meaning treatment of recurrent glioblastoma multiforme. J Neurooncol May;63 1 First-line chemotherapy with topotecan and cancer pancreas traitement experimental in advanced small cell lung cancer.
A phase II study. J Buon Jan-Mar;7 1 The effect of low-dose amiodarone in prevention of paroxysmal atrial fibrillation. Peer-Reviewed Cancer pancreas traitement experimental Articles on behalf of cooperative groups 1. Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues. Breast Cancer Res Treat.
métastatique - Traducere în română - exemple în franceză | Reverso Context
Epub Aug Drug management of prostate cancer: prevalence and consequences of renal insufficiency. Clin Genitourin Cancer.
Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study. Crit Rev Oncol Hematol.
Epub Nov. Lung cancer and renal insufficiency: prevalence and anticancer drug issues. Lung Jan-Feb; 1 Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: The renal insufficiency and anticancer medications IRMA study. Cancer ; 6 Epub July Oudard, E.
Banu, A. Cassar-Queudeville, J. Traitements anti-angiogéniques dans le cancer du rein. Flammarion Médecine-Science. Actualités néphrologiques Banu E. Clinical Trials in Head and Neck Cancers. Oral Presentations 1. Moldovan, B. Angheloiu, B. Moldovan, C. Hpv virus is present, A. Cancer pancreas traitement experimental, E. Banu, G. Proca, R.
Spitalul Sf. Constantin: Dr. Eugeniu Banu
Pintea, I. Cotoara, A. Cotoara, L. Dobrin, C. Cancer cancer pancreas traitement experimental traitement experimental, N. Colonization of patients with multi-resistant bacteria in Romania: is this the top of the aisberg?
Journal of Gastrointestinal and Liver Diseases. Vol 21, suppl Instituirea unui management efficient al institutiilor medicale — de la strategie la rezultate. Conferinta management performant in institutiile medicale din Romania. Hotel Intercontinental Bucuresti 3. Networking, key element in the success in the clinical research business.
Americanii sunt naţiunea care alocă cei mai mulţi bani cercetărilor medicale în domeniul cancerului. Tot ei au şi cele mai multe produse de imunoterapie. Universitatea Stanford anunţa la începutul anului ca a obţinut vindecarea totală a cancerului la cobaii din laborator.
Hilton Athenee Palace. Managementul optim al terapiei in cancerul de prostata. Zilele medicale prahovene. Actualitati in tratamentul si diagnosticul cancerului.
- metastatic - Traduction en français - exemples roumain | Reverso Context
- Traitement symptomatique du carcinome corticosurrénalien évolué non opérable, métastatique ou récidivant.
- Cancer mamar metastaze hepatice
- Posologie de helmintox
Sinaia, Romania. Rolul terapiei hormonale in cancerul de prostata simpozion : Controlul optim al testosteronului in cancerul de prostata. Progrese in Uro-Oncologie II.
City Plaza Hotel. Cluj-Napoca, Romania. CA dynamics during lifetime as prognostic factor for ovarian cancer OC patients. Educational and Abstract Book ;16, suppl cancer pancreas traitement experimental, iiO. J Clin Oncol suppl ;23 16S s A phase II prospective study of gemcitabine and platinum-based combination as firstline chemotherapy for metastatic Bellini duct carcinoma patients. J Clin Oncol suppl cancer pancreas traitement experimental 16S s Banu E: Prostate-specific antigen value in hormone-refractory prostate cancer treated with chemotherapy.
New horizons. Georges Pompidou European Hospital Symposium. Banu E: Isolate biochemical relapse in prostate cancer patients treated with radical prostatectomy or external radiotherapy as primary treatment: recommendations. The 4th West Urological Group Meeting. Ipsen Beaufour Symposium.
June Ile de Bréhat, Assessment of frozen glove use in the prevention of docetaxel induced onycholysis and cutaneous reaction. Results of a multicenter cancer pancreas traitement experimental study.
J Clin Oncol suppl ;22 14S ; Carrefour Pathologie